| Biogen Switzerland AG - Avonex Pen, Injektionslösung in einem Fertigpen |
| 62178 | | 01 | | Avonex Pen | | Injektionslösung in einem Fertigpen | | L03AB07 | | Interferon Beta-1a | | 09.11.2011 | | |
|
| Composition |
| interferonum beta-1a ADNr 30 µg corresp. 6 Mio U.I., natrii acetas trihydricus corresp. natrium 0.13 mg, acidum aceticum glaciale, arginini hydrochloridum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. |
| Packungsbestandteile |
| Injektionslösung in einem Fertigpen | | | | | | | | Active Agent | Dose |
|---|
| Interferonum Beta-1a Adnr | 30 µg |
| | BAG: Active Agent | Dose |
|---|
| Interferonum Beta-1a Adnr | 30 mcg |
| | | | Inactive agents |
|---|
| Acidum Aceticum Glaciale | | Arginine Hydrochloride | | Sodium Acetate Trihydrate | | Polysorbatum 20 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 4 Set(s) | 820.96 | 909.25 | B | SL | Yes |
|
